[{"id":"65ccaf9d-1aaa-48e3-98b4-14d4e6be1110","acronym":"","url":"https://clinicaltrials.gov/study/NCT02096614","created_at":"2021-01-18T09:40:44.722Z","updated_at":"2024-07-02T16:36:28.955Z","phase":"Phase 1","brief_title":"Investigator Initiated Phase 1 Study of TBI-1201","source_id_and_acronym":"NCT02096614","lead_sponsor":"Mie University","biomarkers":" MAGEA4","pipe":" | ","alterations":" MAGEA4 expression • HLA-A*24","tags":["MAGEA4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MAGEA4 expression • HLA-A*24"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fludarabine IV • TBI 1201 • cyclophosphamide intravenous"],"overall_status":"Completed","enrollment":" Enrollment 18","initiation":"Initiation: 04/01/2014","start_date":" 04/01/2014","primary_txt":" Primary completion: 03/01/2021","primary_completion_date":" 03/01/2021","study_txt":" Completion: 03/01/2021","study_completion_date":" 03/01/2021","last_update_posted":"2021-06-18"}]